Clinical Trials in San Francisco

Showing 5161-5180 of 12,991 trials

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

NCT06029478

Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups. This study will admit a wide range of data on the clinical trial experience of chondrosarcoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial. It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future chondrosarcoma patients.

Chondrosarcoma

Power Life Sciences Inc.500 participantsStarted Oct 2024

San Francisco, California, United States

WITHDRAWNPhase 1/2< 1 mile

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

NCT04046107

The purpose of this study is to evaluate the safety and immunotherapeutic activity of cemiplimab in participants with hepatitis B virus (HBV) on suppressive antiviral therapy.

Hepatitis B Virus

National Institute of Allergy and Infectious Diseases (NIAID)Started Jan 2024

San Francisco, California, United States • Atlanta, Georgia, United States • Boston, Massachusetts, United States +5 more locations

Active Not Recruiting< 1 mile

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

NCT00003861

This research trial studies molecular genetic features in blood and tissue samples from patients with newly diagnosed acute lymphoblastic leukemia or acute promyelocytic leukemia. Studying samples of blood and tissue from patients with acute lymphoblastic leukemia or acute promyelocytic leukemia in the laboratory may help doctors identify and learn more about biomarkers related to cancer.

LeukemiaAcute Lymphoblastic LeukemiaAcute Promyelocytic Leukemia

Alliance for Clinical Trials in Oncology840 participantsStarted Apr 1999

San Diego, California, United States • San Francisco, California, United States • Lewes, Delaware, United States +48 more locations

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy

Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia

Find Trials by Condition in San Francisco

Effect of the Erchonia® HLS™ for the Relief of Tinnitus Symptoms

Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

Patiromer Utility as an Adjunct Treatment in Patients Needing Urgent Hyperkalemia Management

A Long-Term Extension Trial in Participants With Atopic Dermatitis Who Participated in Previous EDP1815 Trials

Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia

Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Presbyopia

DE-117 Spectrum 5 Study

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Study to Assess the Efficacy and Safety of Rilonacept Treatment in Participants With Recurrent Pericarditis

Effects of Emicizumab vs. Factor VIII Prophylaxis on Joint and Bone Health in Severe Hemophilia A

Study of Emerfetamab (AMG 673) in Adults With Relapsed/Refractory Acute Myeloid Leukemia (AML)

Intermittent Hypoxia and Caffeine in Infants Born Preterm

Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia

Low-Dose Atropine for Treatment of Myopia

Evidence-based Stimulation Trial With Human rFSH in Europe and Rest of World 2